Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Viveve Medical
(OTCEM:VIVE)
Intraday
$0.0003
0
[0.00%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$0.0003
0
[0.00%]
Last update: 11:51AM
Get Real Time Here
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Viveve Medical Stock (OTC:VIVE)
Viveve Medical Stock (OTC: VIVE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 18, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Jan 18, 2023, 8:06AM
Tuesday, January 17, 2023
Nasdaq Edges Higher; Neovasc Shares Jump
Lisa Levin
-
Jan 17, 2023, 2:50PM
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Jan 17, 2023, 1:21PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Jan 17, 2023, 12:31PM
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Jan 17, 2023, 12:17PM
Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views
Lisa Levin
-
Jan 17, 2023, 12:07PM
Viveve Medical shares are trading lower after the company reported it will seek strategic alternatives and will be delisted from the Nasdaq. The company also announced its treatment for female stress urinary incontinence did not meet the primary endpoint.
Benzinga Newsdesk
-
Jan 17, 2023, 8:46AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Jan 17, 2023, 8:06AM
Viveve Medical Seeks Strategic Alternatives After Failed Stress Urinary Incontinence Trial
Vandana Singh
-
Jan 17, 2023, 8:05AM
Viveve Medical To Seek Strategic Alternatives And Will Be Delisted From Nasdaq; Company Announced Treatment For Female Stress Urinary Incontinence Did Not Meet Primary Endpoint
Charles Gross
-
Jan 17, 2023, 6:27AM
Friday, December 23, 2022
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Dec 23, 2022, 1:24PM
Friday, December 16, 2022
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Dec 16, 2022, 8:07AM
Monday, December 12, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Dec 12, 2022, 10:50AM
Friday, December 02, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Dec 2, 2022, 10:57AM
Tuesday, November 29, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Nov 29, 2022, 11:04AM
Thursday, November 17, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Nov 17, 2022, 10:44AM
Wednesday, November 16, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Nov 16, 2022, 12:16PM
Friday, November 11, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Nov 11, 2022, 12:07PM
Thursday, November 10, 2022
Viveve Medical Q3 EPS $(0.59) Beats $(0.66) Estimate, Sales $1.68M Miss $1.70M Estimate
Benzinga Newsdesk
-
Nov 10, 2022, 4:17PM
Earnings Scheduled For November 10, 2022
Benzinga Insights
-
Nov 10, 2022, 4:23AM
Monday, October 24, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Oct 24, 2022, 11:41AM
Wednesday, October 12, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Oct 12, 2022, 1:32PM
Tuesday, October 04, 2022
Viveve Announces Notice Of Allowance For Second U.S. Method Patent For Treating Female Stress Urinary Incontinence
Benzinga Newsdesk
-
Oct 4, 2022, 8:29AM
Tuesday, September 27, 2022
Viveve Launches Rebranding Initiative To Reflect Focus On Treatment Of Female Stress Urinary Incontinence In Anticipation Of U.S. Pivotal PURSUIT Trial Readout
Benzinga Newsdesk
-
Sep 27, 2022, 8:29AM
Thursday, August 11, 2022
Viveve Medical Q2 EPS $(0.67) Down From $(0.49) YoY
Benzinga Newsdesk
-
Aug 11, 2022, 4:26PM
Earnings Scheduled For August 11, 2022
Benzinga Insights
-
Aug 11, 2022, 5:09AM
Thursday, June 30, 2022
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
Lisa Levin
-
Jun 30, 2022, 4:55AM
Wednesday, June 29, 2022
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Jun 29, 2022, 2:42PM
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Jun 29, 2022, 12:39PM
Monday, June 27, 2022
Ten Stocks Trending on Discord for Monday June 27, 2022: HOOD, EVFM, TSLA, NXTP, AGRX, VIVE, XNCR, COIN, CHWY, NKE
Charles Gross
-
Jun 27, 2022, 8:21PM
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
Lisa Levin
-
Jun 27, 2022, 4:26AM
Thursday, May 26, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
May 26, 2022, 12:15PM
Wednesday, May 25, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
May 25, 2022, 12:14PM
Thursday, May 12, 2022
Recap: Viveve Medical Q1 Earnings
Benzinga Insights
-
May 12, 2022, 5:12PM
Viveve Medical Q1 EPS $(0.67), Inline, Sales $1.60M Miss $1.73M Estimate
Benzinga Newsdesk
-
May 12, 2022, 4:28PM
Earnings Scheduled For May 12, 2022
Benzinga Insights
-
May 12, 2022, 4:55AM
Wednesday, April 27, 2022
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Apr 27, 2022, 5:39PM
Friday, March 18, 2022
Looking Into Viveve Medical's Return On Invested Capital
Benzinga Insights
-
Mar 18, 2022, 10:10AM
Thursday, March 17, 2022
Recap: Viveve Medical Q4 Earnings
Benzinga Insights
-
Mar 17, 2022, 4:24PM
Earnings Scheduled For March 17, 2022
Benzinga Insights
-
Mar 17, 2022, 4:54AM
Wednesday, March 16, 2022
Earnings Preview For Viveve Medical
Benzinga Insights
-
Mar 16, 2022, 11:11AM
Thursday, March 10, 2022
VIVE: Potential game-changer for stress urinary incontinence in women
Zacks Small Cap Research
-
Mar 10, 2022, 8:05AM
Tuesday, December 28, 2021
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Dec 28, 2021, 4:34PM
Monday, December 20, 2021
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Dec 20, 2021, 8:08AM
Tuesday, December 14, 2021
Viveve Announces Completion Of Full Enrollment In Pivotal U.S. PURSUIT Trial For Stress Urinary Incontinence
Benzinga Newsdesk
-
Dec 14, 2021, 8:34AM
Thursday, November 11, 2021
Viveve Medical Q3 EPS $(0.67) Misses $(0.61) Estimate, Sales $1.60M Miss $1.69M Estimate
Benzinga Newsdesk
-
Nov 11, 2021, 4:11PM
Earnings Scheduled For November 11, 2021
Benzinga Insights
-
Nov 11, 2021, 3:55AM
Thursday, October 28, 2021
Viveve Reports Issued New Device, Methods Patent In US
Benzinga Newsdesk
-
Oct 28, 2021, 8:30AM
Thursday, October 21, 2021
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Oct 21, 2021, 4:31PM
Friday, October 08, 2021
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Shanthi Rexaline
-
Oct 8, 2021, 7:31AM
Show more